Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001558370-22-002402
Filing Date
2022-03-01
Accepted
2022-02-28 18:09:22
Documents
5
Effectiveness Date
2022-03-01

Document Format Files

Seq Description Document Type Size
1 S-8 tmb-20220228xs8.htm S-8 110944
2 EX-5.1 tmb-20220228xex5d1.htm EX-5.1 12114
3 EX-23.1 tmb-20220228xex23d1.htm EX-23.1 3925
4 EX-FILING FEES tmb-20220228xexfilingfees.htm EX-FILING FEES 38294
5 GRAPHIC tmb-20220228xex5d1001.jpg GRAPHIC 2549
  Complete submission text file 0001558370-22-002402.txt   169944
Mailing Address 512 2ND STREET, 4TH FLOOR SAN FRANCISCO CA 94107
Business Address 512 2ND STREET, 4TH FLOOR SAN FRANCISCO CA 94107 (415) 651-3316
Olema Pharmaceuticals, Inc. (Filer) CIK: 0001750284 (see all company filings)

EIN.: 300409740 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-263114 | Film No.: 22692334
SIC: 2834 Pharmaceutical Preparations